๐ฐ Outcome Sciences News
Page 2 - Outcome Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Outcome Sciences. Real-time updates on events, politics, business and more.
July 31, 2023
Two Indigenous students are working to provide low-barrier, culturally inclusive access to sexual health care for Indigenous women.
September 21, 2022
Yorba Linda, CA (PRWEB) September 21, 2022 -- Yorba Linda, CA (September 21, 2022) -Labroots, the leading scientific social networking website offering
December 2, 2021
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.
December 1, 2021
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer
November 30, 2021
Our region is awash in calamity. We asked experts for things people can do to protect their mental health.
October 9, 2021
A B.C. study looking into self-isolation through the COVID-19 pandemic has found almost half the participants broke the rules.
April 8, 2021
We must harness digital technology for 21st-century health care By Karimah Es Sabar. Published on Apr 8, 2021 4:16pm While digital health such as telemedicine doesnโt replace the value of face-to-face contact, disruptive technologies such as real-time, embedded monitoring tools will help health-care specialists track and monitor patients without needing to see them. The federal governments COVID-19 Exposure Notification app for smartphones (Health Canada) โHiding within those mou...
February 3, 2021
Study of 5,000 paramedics in B.C. and Ontario led by scientist at the University of B.C. to look at COVID risk while at work.
January 12, 2021
NeonMind Biosciences Inc: NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity NeonMind Biosciences Inc. (CSE: NEON) (" NeonMind"), a psychedelic drug development company, is pleased to announce that it has engaged Dr. C. Laird Birmingham to consult with NeonMind to develop protocols for its Phase 2 Clinical Trial administering psilocybin to treat obese patients. Dr. Birmingham is a Specialist in Internal Medicine, an Epidemi...